CXCR4 rs2228014: What Your Genotype Means
The rs2228014 variant is a common single nucleotide polymorphism located within the CXCR4 gene. Research has investigated this variant for its potential associations with clinical outcomes and disease susceptibility in various types of cancer.
What each genotype means
Common wild-type genotype
This is the most frequently observed genotype for this variant in the general population. Research into this silent mutation at codon 138 of the CXCR4 gene has primarily focused on its potential association with cancer susceptibility and prognosis, though findings remain specific to certain clinical studies and populations.
This is the most common genotype, observed in approximately 70% of individuals in some studied cohorts.
Heterozygous variant carrier
You carry one copy of the variant allele. Some studies have investigated whether this variant, alongside others, influences susceptibility to certain cancers, but results are mixed and often limited to specific clinical contexts. This variant is considered a silent polymorphism, meaning it does not change the amino acid sequence of the CXCR4 protein.
Carried by approximately 1 in 4 individuals in some studied populations.
Homozygous variant carrier
You carry two copies of the variant allele. Some research has suggested a potential association between this genotype and increased susceptibility to or poorer prognosis in certain lung cancer types, though these findings are based on specific case-control studies and are not universal. As this is a silent mutation, it does not alter the protein structure; please discuss any health concerns or cancer risk factors with your clinician.
This is the least common genotype, observed in approximately 4% of individuals in some studied cohorts.
Understanding the rs2228014 Variant
The rs2228014 variant is a single nucleotide polymorphism (SNP) found in the CXCR4 gene, which is located on chromosome 2. In genetic terms, this SNP is often described as a silent mutation at codon 138, meaning that while the DNA sequence changes, the resulting amino acid sequence of the protein typically remains the same. Despite being a silent change, researchers study this variant because it may influence how the gene is regulated or how the protein functions within the body. It is categorized as a trait-associated variant, meaning it has been the subject of studies looking for links between specific genetic patterns and health-related outcomes. Because it is a common variant, it is found frequently across diverse human populations, making it a frequent subject of interest in large-scale genetic association studies.
The Role of the CXCR4 Gene
The CXCR4 gene provides instructions for making a protein called a chemokine receptor. This receptor sits on the surface of various cells and acts like a docking station for a signaling molecule called CXCL12. When CXCL12 binds to CXCR4, it triggers a cascade of signals inside the cell that control essential processes, including cell migration, survival, and the development of the immune system. Because this signaling pathway is so fundamental to how cells move and communicate, it is also heavily involved in how the body responds to inflammation and tissue injury. In the context of cancer research, the CXCR4/CXCL12 axis is frequently studied because it can be "hijacked" by tumor cells to promote their own growth, survival, and spread to other parts of the body, a process known as metastasis.
Research and Clinical Associations
Scientific literature has explored the potential impact of rs2228014 on cancer prognosis and susceptibility. For instance, some studies have observed that patients with specific genotypes, such as the CC genotype, may show different progression-free survival rates compared to those carrying the T allele when undergoing certain chemotherapy regimens. Other research has investigated whether this variant influences the risk of developing conditions like non-small cell lung cancer, with some studies reporting higher odds ratios for individuals carrying the TT genotype. However, it is important to note that the evidence strength for these associations is considered moderate. Results can vary significantly between different study cohorts, and findings are often specific to certain cancer types or treatment protocols. These associations are statistical in nature and do not imply a direct cause-and-effect relationship for any individual patient.
What This Information Means for You
If you have received information about your rs2228014 genotype, it is important to understand that this is a common genetic variation and not a diagnostic tool. The presence of a specific genotype does not predict the development of cancer or determine a specific clinical outcome. Genetic research in this area is primarily used to help scientists understand the biological mechanisms of disease and to potentially identify groups of patients who might respond differently to specific therapies. You cannot use this information to make personal health decisions or to predict your future health. If you are currently undergoing treatment for a medical condition, always discuss your genetic results and any questions about your care with your oncologist or healthcare provider. They are the only ones who can interpret how such information might relate to your specific clinical situation and treatment plan.
How common is this variant?
The rs2228014 variant is considered a common polymorphism, with the C and T alleles appearing frequently across diverse global populations.
Frequently asked questions
Is rs2228014 a mutation that causes cancer?
No, rs2228014 is a common genetic variant, not a disease-causing mutation. While some studies have looked for statistical associations between this variant and cancer outcomes, it is not considered a direct cause of cancer.
Can I use my rs2228014 genotype to predict my cancer risk?
No, you cannot use this information to predict your risk of developing cancer. Genetic associations found in research studies are statistical observations across large groups and do not apply to individual health predictions.
Should I change my treatment based on this SNP?
You should never change your medical treatment based on genetic information without consulting your doctor. Always discuss any questions regarding your medication or treatment plan with your clinician or pharmacist.
What does it mean if my report says this is a 'silent' variant?
A silent variant means that the change in the DNA sequence does not alter the structure of the protein produced by the gene. Researchers still study these variants because they may affect how the gene is expressed or regulated in the cell.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2228014?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29